Martorell, Anthony James,Adaikkan, Chinnakkaruppan,Tsai, Li-Huei,Brown, Emery,Iaccarino, Hannah
申请号：
AU2016361503
公开号：
AU2016361503A1
申请日:
2016.11.23
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present disclosure provides systems and methods for at least one of preventing, reducing, and treating a level of or change in at least one of amyloid-β (Αβ) peptide, C-terminal fragment-β (β-CTF), β-secretase (BACEl), γ-secretase, neuroinflammation, and/or dementia (e.g., Alzheimer's disease or age-related decline) in a subject by inducing synchronized gamma oscillations in the brain of the subject using, for example, a stimulus-emitting device to emit a stimulus (e.g., light, sound, and/or haptic) at a frequency (e.g., about 40 Hz) that synchronously activates
